Compare MQ & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MQ | BHC |
|---|---|---|
| Founded | 2010 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | 2021 | 1996 |
| Metric | MQ | BHC |
|---|---|---|
| Price | $4.38 | $5.77 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 10 | 3 |
| Target Price | $5.36 | ★ $8.00 |
| AVG Volume (30 Days) | ★ 2.7M | 1.4M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 423.08 |
| EPS | ★ N/A | N/A |
| Revenue | $624,884,000.00 | ★ $8,724,000,000.00 |
| Revenue This Year | $16.89 | $4.61 |
| Revenue Next Year | $16.36 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 23.25 | N/A |
| 52 Week Low | $3.70 | $4.41 |
| 52 Week High | $7.04 | $8.69 |
| Indicator | MQ | BHC |
|---|---|---|
| Relative Strength Index (RSI) | 58.13 | 56.13 |
| Support Level | $4.37 | $5.52 |
| Resistance Level | $4.50 | $5.97 |
| Average True Range (ATR) | 0.14 | 0.21 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 77.62 | 33.33 |
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum of its revenue from the Bausch + Lomb segment.